The Microbiome-Metabolokine-Adipokine Axis in Insulin Resistance: Adaptive and Maladaptive FGF21-GDF15 Signaling.

Mustakin PK, Arief M, Nurrahmi K, Kurniawan LB, Amirul Reswara IM

Open source

DOI
10.1210/endrev/bnag038
Published
2026 Oct 19
Container
Endocrine reviews
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1210/endrev/bnag038,
  title = {The Microbiome-Metabolokine-Adipokine Axis in Insulin Resistance: Adaptive and Maladaptive FGF21-GDF15 Signaling.},
  author = {Mustakin PK and Arief M and Nurrahmi K and Kurniawan LB and Amirul Reswara IM},
  year = {2026},
  journal = {Endocrine reviews},
  doi = {10.1210/endrev/bnag038},
  url = {https://doi.org/10.1210/endrev/bnag038}
}

RIS

TY  - JOUR
TI  - The Microbiome-Metabolokine-Adipokine Axis in Insulin Resistance: Adaptive and Maladaptive FGF21-GDF15 Signaling.
AU  - Mustakin PK
AU  - Arief M
AU  - Nurrahmi K
AU  - Kurniawan LB
AU  - Amirul Reswara IM
PY  - 2026
JO  - Endocrine reviews
DO  - 10.1210/endrev/bnag038
UR  - https://doi.org/10.1210/endrev/bnag038
ER  - 

APA

PK, M., M, A., K, N., LB, K., & IM, A. R. (2026). The Microbiome-Metabolokine-Adipokine Axis in Insulin Resistance: Adaptive and Maladaptive FGF21-GDF15 Signaling.. Endocrine reviews. https://doi.org/10.1210/endrev/bnag038

Source records